• SENSEX 76,518.86
    -236.19 (--0.31%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,938.70 1,745.00(%)
  • Bluestone Jewel
    703.40 400.40(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,052.00 710.85(%)
  • M & M Fin. Serv.
    360.00 246.50(%)
  • Data Pattern
    4,238.55 2,131.00(%)
  • TVS Motor Co.
    3,831.45 2,730.00(%)
  • Cummins India
    5,564.75 3,484.00(%)
  • Bajaj Auto
    10,570.75 7,879.45(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    575.90 327.15(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,673.65 3,301.05(%)
  • Nestle India
    1,450.35 1,085.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 72610.0
  • ISIN : INE338H01029
1,283.60 -46 (-3.43%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    1,275.00

  • Today’s High

    1,325.00

  • Open

    1,325.00

  • Perv Close

    1,329.20

  • 52W Low

    987.00

  • 52W High

    1,980.00

Key Indicators

  • P/E(TTM)

    55.92

  • Mar.Cap (₹Cr.)

    13,428.54

  • Div & Yield %

    0.59

  • Book Value(₹)

    193.06

  • Debt-Equity Ratio

    -3.43

  • AGM Date

    22-Jul-2026

  • EPS

    23.03

  • P/E Ratio

    55.92

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    13,428.54

  • RONW (%)

    21.88

  • ROCE (%)

    29.05

Score Board

  • Equity (₹ in Cr.)

    10.46

  • BV (₹)

    193.10

  • Sales( ₹ in Cr.)

    1,055.07

  • NP (in Cr.)

    240.92

  • NP Var(%)

    -30.0

  • Div%

    755.0

  • CPS (₹)

    30.10

  • EPS (₹)

    23.00

  • Traded Value (₹ in Lakhs)

    13,474.04

  • 52 Week High

    1,980.00

  • 52 Week Low

    987.00

  • Price BSE

    1288.0

  • Price NSE

    1,284.00

  • Market Capital( in Cr.)

    13,474.04

  • P/C Ratio

    42.70

  • P/E Ratio

    55.90

  • Price Vs.BV

    23.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,055.07 1,200.09 1,016.94 853.17 712.93 616.94
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,055.07 1,200.09 1,016.94 853.17 712.93 616.94
Other Income 52.73 44.45 33.78 35.31 23.42 13.81
Stock Adjustments 70.61 14.79 12.08 15.63 23.98 39.05
Total Income 1,178.41 1,259.33 1,062.80 904.11 760.33 669.80
EXPENDITURE :            
Raw Materials 316.58 320.30 241.28 195.84 187.99 150.61
Power and Fuel Cost 116.20 112.23 104.97 97.65 71.64 39.86
Employee Cost 170.19 138.93 123.05 110.28 95.69 69.47
Other Manufacturing Expenses 30.77 26.18 28.00 24.93 17.10 12.99
Selling and Administration Expenses 100.88 99.31 91.08 82.93 67.90 44.87
Miscellaneous Expenses 17.28 11.09 8.46 13.20 22.66 10.26
Employee Benefit Expenses 170.19 138.93 123.05 110.28 95.69 69.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 751.89 708.03 596.83 524.84 462.99 328.05
Operating Profit 426.53 551.29 465.97 379.27 297.34 341.74
Interest 0.77 1.04 3.18 5.18 6.13 1.05
Gross Profit 425.76 550.25 462.79 374.09 291.21 340.69
Depreciation 74.33 54.37 53.59 54.03 50.05 27.52
Profit Before Tax 351.43 495.88 409.20 320.06 241.16 313.17
Current Tax 86.29 118.96 99.83 79.53 58.49 75.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.87 3.95 4.63 2.40 4.10 2.11
Reported Net Profit 263.27 372.96 304.73 238.13 178.57 235.33
Extraordinary Items 22.35 27.50 10.48 2.70 3.86 5.24
Adjusted Net Profit 240.92 345.46 294.25 235.43 174.71 230.09
Adjustment below Net Profit 55.78 5.97 -0.01 0.26 -0.56 -0.04
P & L Balance brought forward 1,691.00 1,403.60 1,170.33 985.51 878.02 648.43
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 111.94 91.54 71.45 53.56 70.52 5.71
P & L Balance carried down 1,898.10 1,691.00 1,403.60 1,170.33 985.51 878.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 755.00 875.00 875.00 683.00 51.20 0.00
Dividend Per Share(Rs) 7.55 10.70 8.75 6.83 5.12 0.00
Earnings Per Share-Unit Curr 25.17 35.65 29.13 22.76 187.76 247.44
Earnings Per Share(Adj)-Unit Curr 25.17 35.65 29.13 - - -
Book Value 193.06 173.27 145.80 123.50 1,164.13 1,051.11
Book Value(Adj)-Unit Curr 193.06 173.27 145.80 - - -

Shareholding Pattern

  • Promoter Group

    44.08%

  • Public Share Holding

    55.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,752,000 4.54 4,752,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,364,608 39.54 41,364,608 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 46,116,608 44.08 46,116,608 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,872,315 7.52 7,872,315 95
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,110,826 3.93 4,110,826 5
Mutual Funds / UTI 4,598,027 4.40 4,598,027 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,082,881 1.04 1,082,881 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,664,049 16.88 17,664,049 135
2] Non Institution
Bodies Corporate 2,052,554 1.96 2,052,554 341
Clearing Members 1,123,076 1.07 1,123,076 16
Directors of their Relatives 340,482 0.33 340,482 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 2,092,325 2.00 2,092,325 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,045,266 1.00 1,045,266 1,276
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 225,350 0.22 225,350 2,515
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,256,432 1.20 1,256,432 1
Individuals holding nominal share capital up to Rs. 1 lakh 7,350,127 7.03 7,350,127 78,950
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,199,491 24.09 25,199,491 4
Others 0 0.00 0 0
Sub Total 40,835,547 39.03 40,835,547 83,184
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 104,616,204 100.00 104,616,204 83,325

Company Background

Concord Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Biotech Ltd
  • BSE Code : 72610.0
  • ISIN : INE338H01029

  • Incorporation Year

    1984

  • Registered Office

    1482-86 Trasad Road
    Dholka, Ahmedabad,
    Gujarat-382225

  • Telephone

    91-079-68138700

  • FAX

  • Chairman

    SUDHIR JAIRAM VAID

  • Managing Director

  • Company Secretary

    Paritosh Trivedi

  • Auditor

    BSR & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Concord Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Biotech 1,287.95 1,107.80 1,055.07 51.17 18.33
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77